Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Uniquee


T.VCE

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

  FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On...

July 15, 2022

WKHS

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

  FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On...

July 15, 2022

DKNG

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

  FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On...

July 15, 2022

DKNG

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

June 3, 2022

WKHS

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

June 3, 2022

T.VCE

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

June 3, 2022

T.VCE

FSD Pharma Files Investigational New Drug Application “IND”

  FSD Pharma Files Investigational New Drug Application (“IND”) with...

June 1, 2022

WKHS

FSD Pharma Files Investigational New Drug Application “IND”

  FSD Pharma Files Investigational New Drug Application (“IND”) with...

June 1, 2022

DKNG

FSD Pharma Files Investigational New Drug Application “IND”

  FSD Pharma Files Investigational New Drug Application (“IND”) with...

June 1, 2022

T.VCE

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

  FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets   ...

May 10, 2022

WKHS

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

  FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets   ...

May 10, 2022

DKNG

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

  FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets   ...

May 10, 2022

T.VCE

Lucid-MS for Multiple Sclerosis Treatment

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

May 3, 2022

WKHS

Lucid-MS for Multiple Sclerosis Treatment

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

May 1, 2022

DKNG

Lucid-MS for Multiple Sclerosis Treatment

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 30, 2022

T.VCE

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John...

April 25, 2022

WKHS

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John...

April 24, 2022

DKNG

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John...

April 22, 2022

T.VCE

FSD Pharma Inc: Lucid MS Video

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 19, 2022

WKHS

FSD Pharma Inc: Lucid MS Video

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 17, 2022

1 2 Next